TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Disagreement with enrollment without prospective consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maternal responsiveness to infant cues
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intrusiveness in interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Understanding of screening programme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Study drug-related severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Blood profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Allostatic load scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal saliva cotinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score at 6 months after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lysholm score at 6 months after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Itchiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comparable rates of survival
Endpoint domain: Mortality/survival
Primary endpoint: Averaged measurements in cm/s
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Strain rate in %/s
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: moderate-to-vigorous physical activity duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ATT at heel strike
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ATT at toe off
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total curcuminoid absorption levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcome at 90 days (mRS score ≤1)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Less additional medication for intraoperative sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Instrumental activities of daily living performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Median PaO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median PaCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median CaO2-CcvO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neck Disability Index (NDI) score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in HidroQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of responders for sweat reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in objective MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate in first attempt endotracheal tube placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of attempts overall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitral annular size measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tenting size parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Leaflet length and area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: median rate of gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of time spent with oxygen saturation in the target range during 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of time spent with oxygen saturation in the target range during recovery period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NFRT measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of PNAM therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SGA Success (improvement by 2 grades to clear or very mild disease)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DLQI score of 0 or 1 (no impact of disease on life)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cerebral hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUCinf of acalabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of acalabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions to engage in sun safe behaviour
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: major adverse cardiovascular/cerebrovascular events (MACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endocrine therapy adherence (pill count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cutaneous temperature (CT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental acceptability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median time of referral to PC service to death
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time of referral to outpatient service to death
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palliative care coverage improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of voids in 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in keratinized tissue (KT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nipple redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increase in worry post report-back
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Control of inflammation following LPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Goleghand® compared to PEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Residual gastric fluid retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Generosity toward previously fair opponents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Burden of care
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Quality of life (QOL) of relatives
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life (QOL) scores of patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: fast blood glucose (FBG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight gain from term to 12 weeks CGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant head growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from AF after 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total fentanyl consumption in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to the first analgesic request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: At-rest pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: life quality improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient satisfaction (FLIE scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: best response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants having an ACP/GCD conversation
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: 48-h opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean 48-h pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in SKM methylome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention in group therapy
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Benefit-finding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived improved quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improved body image
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in duration of in‐hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Stress magnitude and distribution in proximal femur
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Exclusive Breastfeeding (EBF) rate
Endpoint domain: Physiological/clinical
Primary endpoint: Proportion of mothers providing water
Endpoint domain: Physiological/clinical
Primary endpoint: WOMAC function or pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate of vitreous hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurocognitive scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decreased functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean MIDAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-to-bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: time-to-discharge/discharge eligibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBcrAg decline at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of AST levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Glutathione (GSH) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BBPS of right colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: BBPS of transverse colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: BBPS of left colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinically significant responses in sleep disorders
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage change in BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: endurance performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete stone clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: weight concerns
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean total SDQ score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: total dry biomass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: photosynthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transpiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced symptoms of social anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduced fear of negative evaluation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: enhanced self-esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proximal nail diameter percentage improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroprotection against measles, mumps, and rubella
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fat-phobic attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TRAT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: student perception questionnaire response rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CFS score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: VAS-A score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Consistency of secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eFAST completion times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transducer ease-of-use rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: minutes/week of muscle-strengthening activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: meeting muscle-strengthening guidelines of 2 or more days/week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Griffiths photoaging scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erythema frequency
Endpoint domain: Adverse events/effects
Primary endpoint: MMP2 mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Stress Scale (PSS) total scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase of γH2AX foci in leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Therapeutic responses to treatment modalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation burden to the patient
Endpoint domain: Adverse events/effects
Primary endpoint: TDI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: operator scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biopsy width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of actionable findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interannotator agreement scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aortic IMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: set-shifting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: central coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical time for third molar extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in Skindex‐16 overall scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Death within 90 days after randomization
Endpoint domain: Mortality/survival
Primary endpoint: New renal-replacement therapy initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Maximum increase in serum creatinine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Modified Rankin scale at 6 months (good 0-2)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acceptability of video counselling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Motivation to try quitting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recommendation of support to family and friends
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Average leg IL-6 release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PDL gene expression profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DGP symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum contents of transmembrane protein 16A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients maintaining glucose levels between 6.7–10 mmol.l−1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of intraoperative hyperglycemic events
Endpoint domain: Adverse events/effects
Primary endpoint: rehospitalisations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of neurological disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Risk of allograft rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bacteria extrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: hemodynamic characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in concentration of S. mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in concentration of L. acidophilus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: donor motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: subsequent donation behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atezolizumab overall survival efficacy
Endpoint domain: Mortality/survival
Primary endpoint: Counts of lymphocytes, CD19+ and CD16+CD56+ immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum TG level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hb1Ac level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Behaviour for carbohydrate counting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sexual/vaginal functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Detection of lipohypertrophy (LH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Serum concentration of Vitamin D at six months of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance of remission to 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coronary self-management scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of re-smoked
Endpoint domain: Adverse events/effects
Primary endpoint: multi-domain cognitive functions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perioperative stroke or death
Endpoint domain: Mortality/survival
Primary endpoint: 1-year stroke or death
Endpoint domain: Mortality/survival
Primary endpoint: interdialytic weight gain (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ultrafiltration volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skills improvement for UAL procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skills improvement for UOAL procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment rate of referred women
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: clinical improvement (Rutherford 0 category)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in negative affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of mobility disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPPB score difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in handgrip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning and memory impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurocognitive functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incisional pain remission time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: craniotomy time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Timeliness of patient reporting
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completeness of data coverage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use